sq-11725 has been researched along with Tachycardia, Supraventricular in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Belli, G; Brambilla, A; Capponi, G; De Simone, L; Favilli, S; Giovannini, M; Porcedda, G; Remaschi, G; Vannuccini, F | 1 |
| Bradley, DJ; Caruthers, R; LaPage, MJ; von Alvensleben, JC | 1 |
| Chidambaram, B; Mehta, AV; Rice, PJ | 1 |
| Chidambaram, B; Mehta, AV | 1 |
| Garson, A | 1 |
| Assoussa, S; Josa, M; Khuri, SF; Leone, L; Okike, ON; Olukotun, AY; Silverman, A; Siouffi, S; Vander Salm, TJ | 1 |
| Klein, GJ; Olukotun, AY | 1 |
| Boccadamo, R; Brown, JE; Calvo, RA; Gadhoke, A; Klein, GJ; Kowey, PR; Olukotun, AY; Saksena, S; Sharma, AD | 1 |
| Deuel, W; Hirzel, H; Rhyner, K; Vetter, W | 1 |
3 trial(s) available for sq-11725 and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Nadolol; Propranolol; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 1992 |
Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting.
Topics: Coronary Artery Bypass; Drug Evaluation; Humans; Hypotension; Nadolol; Postoperative Care; Random Allocation; Tachycardia, Supraventricular | 1987 |
Efficacy and safety of intravenous nadolol for supraventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Female; Heart Rate; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Nadolol; Tachycardia, Supraventricular | 1987 |
6 other study(ies) available for sq-11725 and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Topics: Action Potentials; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Flecainide; Heart Rate; Humans; Infant; Infant, Newborn; Male; Nadolol; Recurrence; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2021 |
Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children.
Topics: Age of Onset; Anti-Arrhythmia Agents; Databases, Factual; Female; Flecainide; Humans; Infant; Infant, Newborn; Male; Michigan; Nadolol; Pediatrics; Retrospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 2017 |
Pharmacokinetics of nadolol in children with supraventricular tachycardia.
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Nadolol; Tachycardia, Supraventricular | 1992 |
Clinical research on children in the 1990s.
Topics: Child; Clinical Trials as Topic; Humans; Nadolol; Tachycardia, Supraventricular | 1992 |
Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Drug Evaluation; Electrocardiography; Electrophysiology; Female; Follow-Up Studies; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Nadolol; Research Design; Safety; Tachycardia, Supraventricular | 1987 |
[Tachycardia, dizziness and weakness].
Topics: Adult; Asthenia; Dizziness; Female; Humans; Mitral Valve Prolapse; Nadolol; Tachycardia, Supraventricular | 1987 |